![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Publisher: Bentham Science Publishers
E-ISSN: 2212-3873|6|4|313-321
ISSN: 1871-5303
Source: Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets - Immune, Endocrine & Metabolic Disorders), Vol.6, Iss.4, 2006-12, pp. : 313-321
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Animal Models of Lupus and Lupus Nephritis
Current Pharmaceutical Design, Vol. 21, Iss. 18, 2015-06 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Leukocyte-mediated Tissue Injury in Ischemic Stroke
Current Medicinal Chemistry, Vol. 21, Iss. 19, 2014-06 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Infliximab: Lupus nephritis: case report
Reactions Weekly, Vol. 1, Iss. 1243, 2009-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Etanercept: Lupus nephritis: case report
Reactions Weekly, Vol. 1, Iss. 1216, 2008-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Newer Drugs for the Treatment of Lupus Nephritis
Drugs, Vol. 63, Iss. 2, 2003-01 ,pp. :